Prothena Biosciences Ltd.
8 clinical trials · Sponsor
◉ Watch Prothena Biosciences Ltd.
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study of PRX019 in Healthy Adult Volunteers (NCT06699680) | Prothena Biosciences Ltd. | 2024-11-08 |
| A Study to Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis (NCT04973137) | Prothena Biosciences Ltd. | 2021-08-30 |
Track Prothena Biosciences Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.